Cargando…
TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form
BACKGROUND: Recent guidelines from the American Thyroid Association (ATA) indicate that, in many patients affected by differentiated thyroid cancer (DTC), the serum TSH should be maintained between 0.1 and 0.5 mU/L. The purpose of this study was to evaluate the TSH variability of patients affected b...
Autores principales: | Cappelli, Carlo, Pirola, Ilenia, Gandossi, Elena, Casella, Claudio, Lombardi, Davide, Agosti, Barbara, Marini, Fiorella, Delbarba, Andrea, Castellano, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441121/ https://www.ncbi.nlm.nih.gov/pubmed/28572820 http://dx.doi.org/10.1155/2017/7053959 |
Ejemplares similares
-
Thyroid Hormone Profile in Patients Ingesting Soft Gel Capsule or Liquid Levothyroxine Formulations with Breakfast
por: Cappelli, Carlo, et al.
Publicado: (2016) -
Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
por: Cappelli, Carlo, et al.
Publicado: (2020) -
Ultrasound Microvascular Blood Flow Evaluation: A New Tool for the Management of Thyroid Nodule?
por: Cappelli, Carlo, et al.
Publicado: (2019) -
Oral Liquid l-Thyroxine (l-T4) May Be Better Absorbed Compared to l-T4 Tablets Following Bariatric Surgery
por: Pirola, Ilenia, et al.
Publicado: (2013) -
Adherence to Levothyroxine Treatment Among Patients With Hypothyroidism: A Northeastern Italian Survey
por: Cappelli, Carlo, et al.
Publicado: (2018)